Events

Africa – Europe 360° cooperation based on equitable R&I partnerships: role and contribution from Switzerland
APR
Wed
09
13:30 - 18:30

This was 7 months ago

Location

Mission of Switzerland to the EU

Place du Luxembourg 1
1050 Brussels
Programmes
Horizon Europe

The University of Bern, The Guild, and SwissCore are jointly organizing a Research and Innovation Briefing on ‘Africa – Europe 360° cooperation based on equitable R&I partnerships: role and contribution from Switzerland’ that will take place at the Mission of Switzerland to the EU on 9 April 2025 (from 13:30), followed by a networking cocktail (from 17:40).

The African Union (AU) and the European Union (EU) adopted in July 2023 the joint AU-EU Innovation Agenda to enhance cooperation in science, technology and innovation. Universities have been engaged and contributing to the priority areas of this agenda and can play an instrumental role in building a competitive, 360-degree approach for Europe’s international partnerships with colleagues in Africa and across the wider global stage.

This event will take a closer look on the Africa-Europe Clusters of Research Excellence (CoRE) launched by the African Research Universities Alliance (ARUA) and The Guild of European Research-Intensive Universities and how this initiative contributed to creating equitable partnerships. Furthermore, leading scientists will present their initiatives, achievements and challenges faced while engaging in international cooperation.

This event will bring Brussels-based stakeholders and policymakers together with Swiss and African scientists to discuss how future policies and programmes should facilitate R&I cooperation between the two continents.

Programme and registration.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.